To Leader McConnell:
“As you know, the Special Diabetes Program (SDP) is part of a set of vital healthcare programs that will expire on December 18th. On Friday, a bipartisan, bicameral group of committee leaders announced agreement on a long-term extension of SDP which was included in the No Surprises Act. This agreement would fund SDP at its’ current levels through FY 2024. The Endocrine Society strongly supports this long-term extension of SDP because it will ensure viable funding for a program that has endured six short-term extensions since September 2019. As you consider an end-of-year funding bill, we urge your support of the bipartisan agreement. The long-term extension of SDP is critical to maintaining the program’s success and would benefit the 122 million people in the country with diabetes or pre-diabetes."
Read the Full Letter
We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.